VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma
Article in Biomolecules and Biomedicine (August 2022)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
The Association of the BRAF-V600E Mutation with the Expression of the Molecular Markers in the Primary Tumor and Metastatic Tissue in Papillary Thyroid Cancer
Article in Asian Pacific Journal of Cancer Prevention (July 2021)
miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma
Article in Human Cell (June 2019)